HRSA Lowers Out-of-Pocket Medication Costs at Health Centers

Fri, 13 Mar 2026 12:31:03 +0000
Healthcare

The Health Resources and Services Administration (HRSA) has issued updated award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. This action aims to lower out-of-pocket costs for life-saving medications nationwide.